Clinical Trial Update: The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing the insulinotropic response of continuous infusion versus bolus injection of glucose-dependent insulinotropic polypeptide (GIP) in Typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GIP (glucose-dependent insulinotropic polypeptide)

Snippet

Sponsor: Diabeteszentrum Bad Lauterberg im Harz | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED